MUHC offers immunocellular therapy for patients with leukemia or lymphoma | McGill University Health Centre
Treatment uses modified white blood cells to target cancer cells that are resistant to standard therapies.
Source: muhc.ca
Stay updated with breaking news from Michael Sebag. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Treatment uses modified white blood cells to target cancer cells that are resistant to standard therapies.